MIssion Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer producing oral, injectable and aseptic medicines with GMP and quality-system focused operations.
MIssion Pharmaceuticals products in Pakistan
MIssion Pharmaceuticals has 47 medicine presentations registered in Pakistan under 29 brands, covering 25 generic medicines. Most of its products are in Anti-infectives, Pain & musculoskeletal and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are Humfex (Cefixime), Mismol (Paracetamol), Cipracept (Ciprofloxacin) and Glovclens (Chlorhexidine gluconate). 47 products have an official DRAP price on MedInfoBase. See all 29 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- Plot No. A-94, S.I.T.E., Super Highway, Karachi, Pakistan
- Website
- missionpharma.com.pk ↗
- Phone
- +92 21 34943857; +92 21 34930755
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where MIssion Pharmaceuticals is priced against the market
33 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Azidrate | Azithromycin | 250 mg | Capsule | 6's | 112573 | PKR 216.13 | PKR 36.02/capsule | 🔒 Pharma Pro |
| Bupicalm | Bupivacaine | 7.5 mg | Injection | 2ml x 10's | 080317 | PKR 517.73 | PKR 25.89/mL | No comparator |
| Cipracept | Ciprofloxacin | 250 mg | Tablet | 10's | 096357 | PKR 224.35 | PKR 22.44/tablet | 🔒 Pharma Pro |
| Cipracept | Ciprofloxacin | 500 mg | Tablet | 10's | 096358 | PKR 371.04 | PKR 37.10/tablet | 🔒 Pharma Pro |
| Clorel | Clopidogrel | 75 mg | Tablet | 1x10's | 080328 | PKR 241.61 | PKR 24.16/tablet | 🔒 Pharma Pro |
| Folever Acid | Folic acid | 5 mg | Tablet | 100's | 091158 | PKR 86.76 | PKR 0.87/tablet | 🔒 Pharma Pro |
| Glovclens | Chlorhexidine gluconate | 4 % | Solution | 500ml | 081610 | PKR 258.87 | PKR 0.52/mL | No comparator |
| Glovclens | Chlorhexidine gluconate | 4 % | Solution | 1000ml | 081610 | PKR 517.73 | PKR 0.52/mL | No comparator |
| Hemolevo | Levofloxacin | 250 mg | Tablet | 1x10's | 112661 | PKR 353.17 | PKR 35.32/tablet | 🔒 Pharma Pro |
| Hemolevo | Levofloxacin | 500 mg | Tablet | 1x10's | 112662 | PKR 587.66 | PKR 58.77/tablet | 🔒 Pharma Pro |
| Humfex | Cefixime | 200 mg/5 mL | Dry suspension | 60ml | 079194 | PKR 690.31 | PKR 11.51/mL | 🔒 Pharma Pro |
| Humfex | Cefixime | 200 mg/5 mL | Dry suspension | 30ml | 079194 | PKR 345.16 | PKR 11.51/mL | 🔒 Pharma Pro |
| Humfex | Cefixime | 100 mg/5 mL | Dry suspension | 60ml | 079195 | PKR 414.19 | PKR 6.90/mL | 🔒 Pharma Pro |
| Humfex | Cefixime | 100 mg/5 mL | Dry suspension | 30ml | 079195 | PKR 207.09 | PKR 6.90/mL | 🔒 Pharma Pro |
| Kacinon | Amikacin | 500 mg | Injection | 2ml x 1's | 081609 | PKR 215.72 | PKR 107.86/mL | 🔒 Pharma Pro |
| Kacinon Injectable | Amikacin | 1.0 g | Injection | 4ml x 1's | 085944 | PKR 358.96 | PKR 89.74/mL | No comparator |
| Maloceft Injection 1g IVRegistry verified | Ceftriaxone | — | — | — | 129126Official source ↗ | No indexed price | — | — |
| Maloceft Injection 250mg IMRegistry verified | Ceftriaxone Sodium Eq. to Ceftriaxone | — | — | — | 129151Official source ↗ | No indexed price | — | — |
| Maloceft Injection 25Omg IVRegistry verified | Ceftriaxone Sodium Eq. to Ceftriaxone | — | — | — | 129130Official source ↗ | No indexed price | — | — |
| Maloceft Injection 2g IVRegistry verified | Ceftriaxone | — | — | — | 129125Official source ↗ | No indexed price | — | — |
| Maloceft Injection 500mg IMRegistry verified | Ceftriaxone Sodium Eq. to Ceftriaxone | — | — | — | 129129Official source ↗ | No indexed price | — | — |
| Maloceft lnjection 1g IMRegistry verified | Ceftriaxone | — | — | — | 129127Official source ↗ | No indexed price | — | — |
| Maloceft lnjection 500mg IVRegistry verified | Ceftriaxone Sodium Eq. to Ceftriaxone | — | — | — | 129128Official source ↗ | No indexed price | — | — |
| Mepalexin | Cephalexin | 500 mg | Capsule | 12's | 079184 | PKR 345.16 | PKR 28.76/capsule | 🔒 Pharma Pro |
| Mepalexin | Cephalexin | 250 mg | Capsule | 12's | 079185 | PKR 172.58 | PKR 14.38/capsule | 🔒 Pharma Pro |
| Miroton | Iron polymaltose complex | 50 mg/5 mL | Syrup | 120ml | 080315 | PKR 229.53 | PKR 1.91/mL | 🔒 Pharma Pro |
| Miroton | Iron polymaltose complex | 50 mg/5 mL | Syrup | 60ml | 080315 | PKR 120.80 | PKR 2.01/mL | 🔒 Pharma Pro |
| Miroton Plus | Elemental iron + Folic acid | 100 mg + 0.35 mg | Chewable tablet | 3x10's | 080327 | PKR 333.08 | PKR 11.10/tablet | No comparator |
| Miroton Plus | Elemental iron + Folic acid | 100 mg + 0.35 mg | Chewable tablet | 1x10's | 080327 | PKR 120.80 | PKR 12.08/tablet | No comparator |
| Misadol | Tramadol HCl | 100 mg | Injection | 5's | 080321 | PKR 241.61 | PKR 48.32/vial/unit | No comparator |
| Misadol Plus | Tramadol + Paracetamol | 37.5 mg + 325 mg | Tablet | 10's | 081607 | PKR 172.58 | PKR 17.26/tablet | 🔒 Pharma Pro |
| Misket 50mg/ml | Ketamine | 50 mg | Injection | 2ml | 080323 | PKR 43.14 | PKR 21.57/mL | 🔒 Pharma Pro |
| Mismol | Paracetamol | 120 mg/5 mL | Suspension | 60ml | 080312 | PKR 66.01 | PKR 1.10/mL | 🔒 Pharma Pro |
| Mismol | Paracetamol | 250 mg/5 mL | Suspension | 60ml | 080313 | PKR 94.97 | PKR 1.58/mL | 🔒 Pharma Pro |
| Mismol | Paracetamol | 500 mg | Tablet | 1000's (Jar) | 098506 | PKR 3,662.16 | — | No comparator |
| Mismol | Paracetamol | 500 mg | Tablet | 20x10's | 098506 | PKR 762.95 | PKR 3.81/tablet | 🔒 Pharma Pro |
| Misofen | Ibuprofen | 100 mg/5 mL | Suspension | 90ml | 081599 | PKR 78.03 | PKR 0.87/mL | 🔒 Pharma Pro |
| Misofen DS | Ibuprofen | 200 mg/5 mL | Suspension | 90ml | 081598 | PKR 103.55 | PKR 1.15/mL | 🔒 Pharma Pro |
| Misofenac | Ibuprofen + Pseudoephedrine | 100 mg + 15 mg/5 mL | Suspension | 60ml | 080314 | PKR 58.06 | PKR 0.97/mL | 🔒 Pharma Pro |
| Misronic | Zoledronic acid | 0.8 mg | Injection | 5ml | 094801 | PKR 25,886.71 | PKR 5,177.34/mL | No comparator |
| Mistin | Simvastatin | 20 mg | Tablet | 10's | 081601 | PKR 310.64 | PKR 31.06/tablet | 🔒 Pharma Pro |
| Mistin | Simvastatin | 10 mg | Tablet | 10's | 081604 | PKR 207.09 | PKR 20.71/tablet | 🔒 Pharma Pro |
| Mixime | Cefixime | 400 mg | Capsule | 5's | 080307 | PKR 526.26 | PKR 105.25/capsule | 🔒 Pharma Pro |
| Musem | Furosemide | 20 mg | Injection | 2ml x 50's | 081608 | PKR 267.50 | PKR 2.68/mL | 🔒 Pharma Pro |
| Omeris | Omeprazole enteric coated pellets | 20 mg | Capsule | 14's | 085946 | PKR 248.51 | PKR 17.75/capsule | 🔒 Pharma Pro |
| Omeris | Omeprazole enteric coated pellets | 40 mg | Capsule | 2x7's | 085947 | PKR 431.45 | PKR 30.82/capsule | 🔒 Pharma Pro |
| Temefan DS Oral | Artemether + Lumefantrine | 30 mg + 180 mg/5 mL | Oral suspension | 30ml | 080309 | PKR 227.74 | PKR 7.59/mL | No comparator |
| Temefan DS Oral | Artemether + Lumefantrine | 30 mg + 180 mg/5 mL | Oral suspension | 60ml | 080309 | PKR 517.73 | PKR 8.63/mL | No comparator |
| Temefan Oral | Artemether + Lumefantrine | 15 mg + 90 mg/5 mL | Oral suspension | 60ml | 080308 | PKR 310.64 | PKR 5.18/mL | No comparator |
| Temefan Oral | Artemether + Lumefantrine | 15 mg + 90 mg/5 mL | Oral suspension | 30ml | 080308 | PKR 136.65 | PKR 4.56/mL | No comparator |
All 29 MIssion Pharmaceuticals brands in Pakistan
- Azidrate Azithromycin · 250 mg capsule
- Bupicalm Bupivacaine · 7.5 mg injection
- Cipracept Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Clorel Clopidogrel · 75 mg tablet
- Folever Acid Folic acid · 5 mg tablet
- Glovclens Chlorhexidine gluconate · 4 % solution
- Hemolevo Levofloxacin · 250 mg tablet, 500 mg tablet
- Humfex Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension
- Kacinon Amikacin · 500 mg injection
- Kacinon Injectable Amikacin · 1.0 g injection
- Mepalexin Cephalexin · 250 mg capsule, 500 mg capsule
- Miroton Iron polymaltose complex · 50 mg/5 mL syrup
- Miroton Plus Elemental iron + Folic acid · 100 mg + 0.35 mg tablet
- Misadol Tramadol HCl · 100 mg injection
- Misadol Plus Tramadol + Paracetamol · 37.5 mg + 325 mg tablet
- Misket 50mg/ml Ketamine · 50 mg injection
- Mismol Paracetamol · 120 mg/5 mL suspension, 250 mg/5 mL suspension, 500 mg tablet
- Misofen Ibuprofen · 100 mg/5 mL suspension
- Misofen DS Ibuprofen · 200 mg/5 mL suspension
- Misofenac Ibuprofen + Pseudoephedrine · 100 mg + 15 mg/5 mL suspension
- Misronic Zoledronic acid · 0.8 mg injection
- Mistin Simvastatin · 10 mg tablet, 20 mg tablet
- Mixime Cefixime · 400 mg capsule
- Musem Furosemide · 20 mg injection
- Omeris Omeprazole enteric coated pellets · 20 mg capsule, 40 mg capsule
- Temefan DS Oral Artemether + Lumefantrine · 30 mg + 180 mg/5 mL suspension
- Temefan Oral Artemether + Lumefantrine · 15 mg + 90 mg/5 mL suspension
- TRANEX Tranexamic acid · 250 mg capsule, 500 mg capsule
- Vorenac Diclofenac · 50 mg tablet, 75 mg injection
MIssion Pharmaceuticals: common questions
How many products does MIssion Pharmaceuticals have in Pakistan?
MIssion Pharmaceuticals has 47 registered medicine presentations in Pakistan, sold under 29 brands and covering 25 generic medicines.
What are the main brands of MIssion Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Humfex (Cefixime), Mismol (Paracetamol), Cipracept (Ciprofloxacin), Glovclens (Chlorhexidine gluconate) and Hemolevo (Levofloxacin). This is not a sales ranking.
Which therapy areas does MIssion Pharmaceuticals cover?
The most products are in Anti-infectives (20), Pain & musculoskeletal (10), Vitamins, minerals & nutrition (5), Hematology & thrombosis (3) and Cardiovascular (3).
Where can I see MIssion Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.